Lu and his team have faced challenges and produced encouraging, yet complex results. Learn about his journey and his passion.
Lu Alleruzzo received a bachelor’s degree in bioengineering and an MBA from the University of Missouri – Columbia. He is a co-founder and the COO of Immunophotonics, a biotech company that has developed inCVAX, an in situ autologous cancer vaccine for the treatment of advanced solid tumor cancers.
This talk was given at a TEDx event using the TED conference format but independently organized by a local community. Learn more at http://ted.com/tedx